These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16822527)

  • 1. Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats.
    Xia HJ; Dai DZ; Dai Y
    Life Sci; 2006 Oct; 79(19):1812-9. PubMed ID: 16822527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent.
    Du RH; Yi HW; Dai DZ; Tang WH; Dai Y
    J Pharm Pharmacol; 2008 Aug; 60(8):1089-95. PubMed ID: 18644201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017.
    Na T; Huang ZJ; Dai DZ; Zhang Y; Dai Y
    Acta Pharmacol Sin; 2007 Jun; 28(6):773-82. PubMed ID: 17506935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated FKBP12.6 expression and upregulated endothelin signaling contribute to elevated diastolic calcium and arrhythmogenesis in rat cardiomyopathy produced by l-thyroxin.
    Zhang Y; Huang ZJ; Dai DZ; Feng Y; Na T; Tang XY; Dai Y
    Int J Cardiol; 2008 Nov; 130(3):463-71. PubMed ID: 18684528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy.
    Feng Y; Dai DZ; Na T; Cui B; Wang T; Zhang Y; Dai Y
    Pharmacol Rep; 2007; 59(3):306-14. PubMed ID: 17652831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats.
    Qi MY; Xia HJ; Dai DZ; Dai Y
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):729-35. PubMed ID: 16810072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats.
    He HB; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2006 Sep; 27(9):1213-21. PubMed ID: 16923343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of darusentan: a novel endothelin receptor antagonist.
    Epstein BJ
    Ann Pharmacother; 2008 Jul; 42(7):1060-9. PubMed ID: 18523233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failure.
    Bergler-Klein J; Pacher R; Berger R; Bojic A; Stanek B
    J Heart Lung Transplant; 2004 Jan; 23(1):20-7. PubMed ID: 14734123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total triterpene acids, active ingredients from Fructus Corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocin-rats.
    Qi MY; Liu HR; Dai DZ; Li N; Dai Y
    J Pharm Pharmacol; 2008 Dec; 60(12):1687-94. PubMed ID: 19000375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni.
    Su W; Dai DZ; Liu HR; Na T; Dai Y
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1228-33. PubMed ID: 17973859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
    Jesmin S; Zaedi S; Maeda S; Yamaguchi I; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):925-31. PubMed ID: 16741025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
    Lüscher TF; Enseleit F; Pacher R; Mitrovic V; Schulze MR; Willenbrock R; Dietz R; Rousson V; Hürlimann D; Philipp S; Notter T; Noll G; Ruschitzka F;
    Circulation; 2002 Nov; 106(21):2666-72. PubMed ID: 12438291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial.
    Anand I; McMurray J; Cohn JN; Konstam MA; Notter T; Quitzau K; Ruschitzka F; Lüscher TF;
    Lancet; 2004 Jul 24-30; 364(9431):347-54. PubMed ID: 15276394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of FKBP12.6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signalling pathway.
    He HB; Yu F; Dai DZ; Dai Y
    J Pharm Pharmacol; 2007 Jul; 59(7):977-84. PubMed ID: 17637193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism.
    Mitchell A; Lückebergfeld B; Bührmann S; Rushentsova U; Nürnberger J; Siffert W; Schäfers RF; Philipp T; Wenzel RR
    Clin Pharmacol Ther; 2004 Nov; 76(5):396-408. PubMed ID: 15536455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endothelin receptor antagonists on endothelin-1 and inducible nitric oxide synthase genes in a rat endotoxic shock model.
    Hirata Y; Ishimaru S
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():332S-335S. PubMed ID: 12193116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
    Circulation; 2005 Jan; 111(3):302-9. PubMed ID: 15642760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis.
    Li TH; Lee PC; Lee KC; Hsieh YC; Tsai CY; Yang YY; Huang SF; Tsai TH; Hsieh SL; Hou MC; Lin HC; Lee SD
    Sci Rep; 2016 Dec; 6():39405. PubMed ID: 28009008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of hydroxysafflor yellow A on diabetic cardiac insufficiency attributed to up-regulation of the expression of intracellular calcium handling proteins of sarcoplasmic reticulum in rats.
    He H; Liu Q; Shi M; Zeng X; Yang J; Wu L; Li L
    Phytother Res; 2008 Aug; 22(8):1107-14. PubMed ID: 18570267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.